牛牛AI助理已提取核心訊息
Bruush Oral Care Inc. has been notified by the Nasdaq Listing Qualifications Department that it no longer meets the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company's common shares have not maintained the required $1.00 per share minimum bid price for 30 consecutive trading days, as stipulated by Nasdaq Listing Rule 5550(a)(2). Bruush Oral Care was given until May 13, 2024, to regain compliance. However, the situation worsened when the company's shares closed at $0.10 or less for ten consecutive trading days, violating the Nasdaq's Low Priced Stocks Rule. Consequently, Nasdaq has decided to delist Bruush Oral Care's securities, with trading suspension set to commence on March 7, 2024, unless the company appeals by March 5, 2024. Bruush Oral Care has requested a hearing before the Nasdaq Hearings Panel, which is scheduled for April 25, 2024, where the company will present a plan to regain compliance. The outcome of the hearing and the company's ability to meet Nasdaq's continued listing requirements remain uncertain.
Bruush Oral Care Inc. has been notified by the Nasdaq Listing Qualifications Department that it no longer meets the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company's common shares have not maintained the required $1.00 per share minimum bid price for 30 consecutive trading days, as stipulated by Nasdaq Listing Rule 5550(a)(2). Bruush Oral Care was given until May 13, 2024, to regain compliance. However, the situation worsened when the company's shares closed at $0.10 or less for ten consecutive trading days, violating the Nasdaq's Low Priced Stocks Rule. Consequently, Nasdaq has decided to delist Bruush Oral Care's securities, with trading suspension set to commence on March 7, 2024, unless the company appeals by March 5, 2024. Bruush Oral Care has requested a hearing before the Nasdaq Hearings Panel, which is scheduled for April 25, 2024, where the company will present a plan to regain compliance. The outcome of the hearing and the company's ability to meet Nasdaq's continued listing requirements remain uncertain.
納斯達克上市資格部門已通知Bruush Oral Care Inc.，它不再符合繼續在納斯達克資本市場上市的最低出價要求。根據納斯達克上市規則5550（a）（2）的規定，該公司的普通股連續30個交易日未維持每股1.00美元的最低出價要求。Bruush 口腔護理一直持續到 2024 年 5 月 13 日，以恢復合規性。但是，當該公司股票連續十個交易日收於0.10美元或以下，這違反了納斯達克的《低價股票規則》，情況惡化了。因此，納斯達克決定將Bruush Oral Care的證券除名，除非該公司在2024年3月5日之前提出上訴，否則定於2024年3月7日開始暫停交易。Bruush Oral Care已要求在定於2024年4月25日舉行的納斯達克聽證會小組舉行聽證會，該公司將在會上提出恢復合規的計劃。聽證會的結果以及該公司滿足納斯達克持續上市要求的能力仍不確定。
納斯達克上市資格部門已通知Bruush Oral Care Inc.，它不再符合繼續在納斯達克資本市場上市的最低出價要求。根據納斯達克上市規則5550（a）（2）的規定，該公司的普通股連續30個交易日未維持每股1.00美元的最低出價要求。Bruush 口腔護理一直持續到 2024 年 5 月 13 日，以恢復合規性。但是，當該公司股票連續十個交易日收於0.10美元或以下，這違反了納斯達克的《低價股票規則》，情況惡化了。因此，納斯達克決定將Bruush Oral Care的證券除名，除非該公司在2024年3月5日之前提出上訴，否則定於2024年3月7日開始暫停交易。Bruush Oral Care已要求在定於2024年4月25日舉行的納斯達克聽證會小組舉行聽證會，該公司將在會上提出恢復合規的計劃。聽證會的結果以及該公司滿足納斯達克持續上市要求的能力仍不確定。
有用
沒用